Discontinued — last reported Q4 '25
Operating
Change in AP
Eli Lilly Change in AP remained flat by 0.0% to $2.55B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 290.5%, from $652.20M to $2.55B. Over 4 years (FY 2021 to FY 2025), Change in AP shows an upward trend with a 97.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalHigher is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ4 2025
How to read this metric
An increase suggests the company is successfully leveraging its scale to negotiate better payment terms with its supply chain.
Detailed definition
Accounts payable represents the change in the amount the company owes to its suppliers for materials or services purchas...
Peer comparison
Dominant market leaders often have high accounts payable as they can dictate longer payment terms to their vendors.
Metric ID:
change_in_accounts_payableHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | -$664.10M | $1.33B | $4.27B | $2.61B | $10.19B |
| YoY Change | — | +300.5% | +221.0% | -39.0% | +290.5% |
Range-$664.10M – $10.19B
CAGR+97.9%
Avg YoY Growth+193.3%
Median YoY Growth+255.7%
Change in AP at Other Companies
Frequently Asked Questions
- What is Eli Lilly's change in ap?
- Eli Lilly (LLY) reported change in ap of $2.55B in Q4 2025.
- How has Eli Lilly's change in ap changed year-over-year?
- Eli Lilly's change in ap increased by 290.5% year-over-year, from $652.20M to $2.55B.
- What is the long-term trend for Eli Lilly's change in ap?
- Over 4 years (2021 to 2025), Eli Lilly's change in ap has grown at a 97.9% compound annual growth rate (CAGR), from -$664.10M to $10.19B.
- What does change in ap mean?
- The change in the amount of money the company owes to its suppliers.